Quantcast

Latest Pharmacology Stories

2014-06-25 08:31:17

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Leukemia, Melanoma and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_leukemia_melanoma_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated according to...

2014-06-25 08:31:13

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Lymphoma, Melanoma and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_lymphoma_melanoma_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated according to...

2014-06-25 08:30:55

GREENWOOD VILLAGE, Colo., June 25, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has informed the Transplant and Ophthalmology Division of the FDA of its intent to reduce the patient sample size in the OptimEyes Study for the treatment of Diabetic Macular Edema (oral treatment with Optina(TM)). This trial was intended to enroll 450 patients and was powered at 95%. The present enrollment of over 355 patients provides an adequate power of 88%,...

2014-06-25 08:30:28

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Leukemia, Lung Cancer and Melanomahttp://www.reportbuyer.com/pharma_healthcare/diseases/triple_analysis_leukemia_lung_cancer_melanoma.html This triple analysis focuses on cancer drug development strategies in Leukemia, Lung Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment...

2014-06-25 08:29:57

-- Company's License Covers C-IBS, Type 2 Diabetes and Obesity -- ROCKVILLE, Md., June 25, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, today announced that researchers at Cedars-Sinai Medical Center (Cedars-Sinai) found that eradication of breath methane and reduction of intestinal levels of the most common methanogenic...

2014-06-25 08:28:04

Report Highlights 113 Products, a 57 Percent Increase in the Last Three Years WASHINGTON, June 25, 2014 /PRNewswire-USNewswire/ -- The Personalized Medicine Coalition (PMC) announced today the release of the fourth edition of the organization's signature document, The Case for Personalized Medicine. http://photos.prnewswire.com/prnvar/20130517/DC16280LOGO The report notes the steady development of the personalized medicine field, with a 57 percent increase in products the last three years. In...

2014-06-25 04:20:59

LEXINGTON, Massachusetts, June 25, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Judge Stanley R. Chesler of the U.S. District Court for the District of New Jersey granted Shire's summary judgment motion in a patent infringement lawsuit, holding that certain claims of the patents protecting Vyvanse(R) (lisdexamfetamine dimesylate) were both infringed and valid. The ruling prevents the five pharmaceutical manufacturers (the ANDA Defendants) who...

2014-06-24 23:16:24

PINNAKLE uncovers unrealized brand opportunity in the pharma industry. New York, NY (PRWEB) June 24, 2014 Kantar Health, a leading global healthcare consulting firm, today announced the introduction of PINNAKLE™, an integrated, holistic brand marketing solution that helps pharmaceutical companies maximize commercial success for their medicines by finding their unrealized brand opportunity. A unique and revolutionary approach, PINNAKLE optimizes brand performance through the seamless...

2014-06-24 23:14:41

There are several common mistakes in ANDA submissions that can be avoided to ensure speedy approval. Learn what those mistakes are and what to do about them on July 15 at the FDAnews webinar led by 30-year industry expert Dr. Andy Papas, Vice President of Regulatory Affairs at NSF Health Sciences Pharma Biotech. Falls Church, VA (PRWEB) June 24, 2014 Expedite Your FDA Generic Drug Approval: Deliver Flawless ANDAs the First Time **FDAnews Webinar** July 15, 2014 — 1:30 p.m. – 3:00...

2014-06-24 23:14:00

Cancer Treatment and Wellness Center is one of the first sites in the world to provide patients with access to leading edge breast cancer drug trial PALOMA-3. Westchester County, NY (PRWEB) June 24, 2014 The Cancer Treatment and Wellness Center at Northern Westchester Hospital is now enrolling patients for a clinical research study investigating the use of palbociclib (PD-0332991), a CDK 4/6 inhibitor being investigated for advanced stage breast cancer. CDK proteins can be involved in...


Latest Pharmacology Reference Libraries

Pharmacophobia
2013-12-24 12:55:45

Pharmacophobia or medication phobia, comes from Greek pharmakon, meaning “drug, medicine” and phobos, meaning “fear”, is the fear of the use of pharmacological treatments. In severe, excessive, and irrational cases, it might be a type of specific phobia. While lack of awareness by patient of adverse drug reactions can have a serious consequence, having a phobia of medications can also have serious detrimental effects on the patient’s health. Medication phobia can also lead to...

Generalized Anxiety Disorder
2013-07-25 15:07:54

Generalized Anxiety Disorder (GAD) is an anxiety disorder with worry about normal, everyday situations such as finance, health and wellbeing in relationships (personal and work related) all lasting longer than six months. Symptoms The symptoms of GAD can include but are not limited to difficulty swallowing, rashes, shortness of breath, fidgeting, headaches, tension, nausea, etc. In order for GAD to be ruled as present, the symptoms and feelings must be experiences for at least six...

European Journal of Medical Chemistry
2012-05-12 22:03:06

The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...

0_3ff7149ca288229c28bcd855846ea8c7
2009-04-28 16:00:11

Bursera graveolens or Palo Santo is a tree indigenous to South America in Argetina, Paraguay, Boliva and coastal areas of Ecuador. Palo Santo means "holy wood" in English and belongs in the same family as frankincense and myrrh. Although it has been used in homeopathic medicine for years, most recently it is the extraction of essential oils that has put this plant in the spotlight. Limonene, a-Terpineol, Menthofuran and Carvone are a few of the oils derived from this plant. Native...

31_c737ff73aa3c47be364b2a8cce214e0c
2005-07-12 18:32:21

Datura wrightii (a poisonous weed) is sometimes used as a hallucinogen. It is commonly called Sacred Datura. Datura wrightii is classified as a deliriant, or an anticholinergic. In the US it is, however, called Western Jimson Weed.

More Articles (5 articles) »
Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.